The introduction of Retatrutide ZPHC, at a strength of 120mg, is creating considerable buzz within the medical community. This innovative dual GIP and GLP-1 agonist medication seems to deliver impressive improvements in fat shedding compared to existing therapies. Initial research trials have shown